作者: Lea S. Eiland , Paige K. Luttrell
DOI: 10.5863/1551-6776-15.3.160
关键词:
摘要: Abstract Childhood dyslipidemia is on the rise and increasingly being recognized as an important risk factor for adult cardiovascular disease. Due to a heightened awareness surrounding this problem, American Academy of Pediatrics published clinical report concerning prevention, screening, diagnosis, treatment in children. Of concern among practitioners when initiate pharmacologic therapy which medications are safe appropriate The addresses by suggesting that management begin only pediatric patients with substantially elevated LDL levels. Since statins drugs choice levels, it would be evaluate their outcome patients. To efficacy safety dyslipidemia, comprehensive search was performed MEDLINE database International Pharmaceutical Abstracts well references from addit...